secwatch.observer — SEC 8-K summary
======================================

Issuer:     NutriBand Inc. (NTRB)
CIK:        0001676047
Form:       8-K
Filed at:   2024-12-30T23:59:59+00:00
Accession:  0001213900-24-113463
Event type: regulatory
Sentiment:  positive
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutriband extends AVERSA patent to Macao; now covered in 46 countries
---------------------------------------------------------------------

- Macao IP Office assigned patent number J/9010 with entry date December 17, 2024.
- AVERSA abuse-deterrent technology now patented in 46 countries and territories.
- Company targets FDA submission for AVERSA Fentanyl in first half of 2025.
- AVERSA Fentanyl has potential peak US sales of $80M to $200M per Health Advances report.
- Partnership with Kindeva Drug Delivery for lead product using FDA-approved fentanyl patch system.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676047/000121390024113463/0001213900-24-113463-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676047/000121390024113463/ea0226333-8k_nutri.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-113463

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer